LEADER 01793oam  2200469   450 
001 9910713398703321
005 20200323090025.0
035   $a(CKB)5470000002499652
035   $a(OCoLC)80158883
035   $a(EXLCZ)995470000002499652
100   $a20070126d2006      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFollow-up review of the Drug Enforcement Administration's efforts to control the diversion of controlled pharmaceuticals /$fU.S. Department of Justice, Office of the Inspector General, Evaluation and Inspection Division
210  1$a[Washington, D.C.] :$cU.S. Department of Justice Office of the Inspector General, Evaluation and Inspections Division,$d2006.
215   $a1 online resource (vii, 79 pages) $cillustrations
225 1 $aReport ;$vI-2006-004
300   $a"July 2006."
300   $aReport number from the Office of Inspector General, U.S. Department of Justice's "All reports" page.
300   $aIncludes tables.
320   $aIncludes bibliographical references.
606   $aDrug control$zUnited States
606   $aInternet pharmacies$xCorrupt practices$zUnited States
606   $aDrug traffic$xInvestigation$zUnited States
615  0$aDrug control
615  0$aInternet pharmacies$xCorrupt practices
615  0$aDrug traffic$xInvestigation
801  0$bZCY
801  1$bZCY
801  2$bZCY
801  2$bOCLCQ
801  2$bOCLCA
801  2$bOCLCQ
801  2$bOCLCF
801  2$bGPO
906   $aBOOK
912   $a9910713398703321
996   $aFollow-up review of the Drug Enforcement Administration's efforts to control the diversion of controlled pharmaceuticals$93331262
997   $aUNINA